Infinity Pharma Revenue, Profits - INFI Quarterly Income Statement

Add to My Stocks
$2.4 $0.09 (3.9%) INFI stock closing price Sep 21, 2018 (Closing)

Fundamental analysis of INFI stock involves analyzing its financial statements, apart from checking the Infinity Pharma stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the INFI stock is bound to reflect the impact of the QOQ decline of 0. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Infinity Pharma profit and loss statement with those of the prior corresponding period. Also see Infinity Pharma assets and Infinity Pharma free cash flow for a complete valuation of INFI stock.

View and download details of revenue and profits for Infinity Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Infinity Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Infinity Pharma Gross Profit
Research & Development Expense3.74M5.91M3.57M9.33M3.9M4.03M14.68M12.81M52.94M39.18M
Selling General & Admin Expense3.38M3.6M4.48M4.5M6.2M6.43M8.58M7.12M-96.52M10.83M
Income Before Depreciation Depletion Amortization-7.13M-9.51M-8.03M-7.84M-10.1M-10.47M-23.24M-19.93M53.04M-40.76M
Depreciation Depletion Amortization----------
Non Operating Income---1.02M-6.54M-----
Interest Expense----------
Infinity Pharma Pretax Income
Provision for Income Taxes---0.72M-------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-6.96M-9.45M-7.3M-7.1M-16.95M-10.48M-22.93M-19.5M52.99M-40.66M
Extraordinary Items & Discontinued Operations----------
Infinity Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS55.97M51.88M50.72M50.64M50.46M50.42M50.1M49.58M49.44M49.34M
Average Shares used to compute Basic EPS55.97M51.88M50.72M50.64M50.46M50.42M50.1M49.58M49.44M49.34M
Income Before Nonrecurring Items-6.96M-9.45M-7.3M-7.1M-16.95M-10.48M-22.93M-19.5M-19.95M-40.66M
Income from Nonrecurring Items--------72.94M-
Infinity Pharma Earnings Per Share Basic Net
Infinity Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.12-0.18-0.14-0.14-0.34-0.21-0.46-0.39-0.43-0.82
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Infinity Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Infinity Pharma revenue chart, as isn't the case with Infinity Pharma indicates a sagging business. One needs to compare the QoQ topline or sales growth of INFI stock with its peers like KURU stock and ITRM stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-6.96M for Infinity Pharma for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the INFI income statement, one can check the Infinity Pharma historical stock prices to check how the price has moved with time.

Infinity Pharma Income Statement - Key Financial Ratios

Operating Margin
Net Profit Margin